|
| ID |
DDInter39 |
| Drug Type |
small molecule |
| Molecular Formula |
C30H34N4O2 |
| Molecular Weight |
482.628
|
| Description |
Alectinib is a kinase inhibitor used to treat anaplastic lymphoma kinase positive metastatic non small cell lung cancer.
|
| ATC Classification |
L01XE36
|
| IUPAC Name |
9-Ethyl-6,6-Dimethyl-8-[4-(Morpholin-4-Yl)Piperidin-1-Yl]-11-Oxo-5H,6H,11H-Benzo[B]Carbazole-3-Carbonitrile |
| InChI |
Inchi=1S/C30H34N4O2/C1-4-20-16-23-24(17-26(20)34-9-7-21(8-10-34)33-11-13-36-14-12-33)30(2,3)29-27(28(23)35)22-6-5-19(18-31)15-25(22)32-29/H5-6,15-17,21,32H,4,7-14H2,1-3H3 |
| InChI Key |
KDGFLJKFZUIJMX-UHFFFAOYSA-N |
| Canonical SMILES |
CCC1=CC2=C(C=C1N1CCC(CC1)N1CCOCC1)C(C)(C)C1=C(C3=CC=C(C=C3N1)C#N)C2=O |
| Useful Links |
DrugBank
ChEMBL
PubChem
|